Why the study?
Data on the role of insurance status on outcomes in patients with NSTEMI are limited in the contemporary era.
Does primary payer insurance status influence in-hospital mortality and invasive procedure utilization in adults hospitalized with NSTEMI?
Cohort (n=7,290,565)
Yes
Does primary payer insurance status influence in-hospital mortality and invasive procedure utilization in adults hospitalized with NSTEMI?
Across 7.29 million US NSTEMI admissions over 18 years, Medicare beneficiaries underwent significantly fewer invasive coronary procedures (angiography, PCI, CABG) and experienced higher adjusted in-hospital mortality compared to privately insured and Medicaid patients.
Payer status may signal NSTEMI mortality disparities; leaves open whether effects are causal or reflect unmeasured confounding in observational data.
Background: The role of insurance on outcomes in non-ST-segment-elevation myocardial infarction (NSTEMI) patients is limited in the contemporary era.Methods: From the National Inpatient Sample, adult NSTEMI admissions were identified [2000–2017]. Expected primary payer was classified into Medicare, Medicaid, private, uninsured and others. Outcomes included in-hospital mortality, overall and early coronary angiography, percutaneous coronary intervention (PCI), resource utilization and discharge disposition.Results: Of the 7,290,565 NSTEMI admissions, Medicare, Medicaid, private, uninsured and other insurances were noted in 62.9%, 6.1%, 24.1%, 4.6% and 2.3%, respectively. Compared to others, those with Medicare insurance older (76 vs. 53–60 years), more likely to be female (48% vs. 25–44%), of white race, and with higher comorbidity (all P<0.001). Population from the Medicare cohort had higher in-hospital mortality (5.6%) compared to the others (1.9–3.4%), P<0.001. With Medicare as referent, in-hospital mortality was higher in other {adjusted odds ratio (aOR) 1.15 [95% confidence interval (CI), 1.11–1.19]; P<0.001}, and lower in Medicaid [aOR 0.95 (95% CI, 0.92–0.97); P<0.001], private [aOR 0.77 (95% CI, 0.75–0.78); P<0.001] and uninsured cohorts [aOR 0.97 (95% CI, 0.94–1.00); P=0.06] in a multivariable analysis. Coronary angiography (overall 52% vs. 65–74%; early 15% vs. 22–27%) and PCI (27% vs. 35–44%) were used lesser in the Medicare population. The Medicare population had longer lengths of stay, lowest hospitalization costs and fewer home discharges.Conclusions: Compared to other types of primary payers, NSTEMI admissions with Medicare insurance had lower use of coronary angiography and PCI, and higher in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
Vallabhajosyula et al. (2021) conducted a cohort in Non-ST-segment elevation myocardial infarction (NSTEMI) (n=7,290,565). Private insurance (and Medicaid, uninsured, other primary payers) vs. Medicare insurance (referent) was evaluated on In-hospital mortality (OR 0.77, 95% CI 0.75-0.78, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: